• Metyrapone Stimulation Test (MST)
  • Wet Mount from Vaginal Fluid (Vaginal Swab)
  • Metabolic Storage Disease Gene Mutation Panel, NGS
  • Vascular Endothelial Growth Factor (VEGF)
  • Listeria, Culture, Blood
  • Beta-2 Microglobulin, Serum
  • Lysoganglioside GM1 Antibody, IgG
  • Adrenoleukodystrophy
  • HIV1/HIV2 Antibody Screen, 3rd Generation
  • Circulating Tumor Cells (CTC), Breast Cancer (Cellsearch®)
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants
Medical Test

Additional ICD10
Access to Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants is restricted.